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Inadequate healing of myocardial infarction may contribute to local expansion of the infarct, frequently leading to chamber
dilation, heart failure, or myocardial rupture. Experimental evidence in mouse models suggests that Factor XIII might play a key
role in wound healing, and low persistent values lead to increased incidence of cardiac rupture following myocardial infarction.
Here we would like to share our initial clinical experiences with strikingly similar observations in patients with this grave
disease, and compare these observations to experimental findings.
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INTRODUCTION
Inadequate healing of myocardial infarction may contribute to
local expansion of the infarct, frequently leading to chamber
dilation, heart failure, or myocardial rupture [1]. Experimental
evidence in mouse models suggests that Factor XIII might play
a key role in wound healing and low persistent values lead to
increased incidence of cardiac rupture following myocardial
infarction. For example in heterozygous FXIII deficient mice
(characterized by 50% plasma levels of FXIII) 100% die from
cardiac rupture following MI (Figure 1 A–C) and FXIII
replacement therapy reverts these findings [2]. Here we would
like to share our initial clinical experiences with strikingly similar
observations in patients with this grave disease.
RESULTS AND DISCUSSION
We investigated FXIII levels in three consecutive patients
presenting with acute myocardial rupture following myocardial
infarction. FXIII levels in these patients were only 5768% of
normal (Figure 1 D), whereas all other coagulation tests were
normal or not consistently altered. One patient suffered a rupture
of the ventricular septum 7 days following MI, presenting with
sudden onset of cardiogenic shock and a new systolic heart
murmur. The diagnosis was confirmed by Doppler (Figure 1 E).
Cardiac catheterization showed a shunt volume of 66% and severe
coronary artery disease. Therefore, surgical closure of the 2 cm
VSD (Figure 1 F) was combined with coronary artery bypass
grafting utilizing the patient’s saphenous veins. Six days later the
patient presented again in cardiogenic shock, this time from
a ruptured papillary muscle causing severe mitral valve in-
sufficiency. The valve was replaced on the same day. Healing of
the thoracotomy wound and lower extremity incisions was delayed
for over 2 months (Figure 1 G–I), necessitating 3 surgical revisions.
Repetitive swabs excluded infection, and the patient was not
diabetic. During this time, FXIII levels were consistently reduced
to 50%. Following the third revision, we initiated intravenous
FXIII supplementation therapy (Fibrogammin 1,250 IE) and the
skin wounds healed two weeks later (Figure 1 J). The other two
patients died within 2 weeks after admission in cardiogenic shock.
To determine whether a truly causative relationship existed
between FXIII activity and myocardial healing, we have recently
studied myocardial repair in FXIII deficient mice [2]. All
FXIII
2/2 and FXIII
2/+ mice died within 5 days after MI from
left ventricular (LV) rupture and had locally reduced levels of
FXIII as determined by imaging [2]. In contradistinction,
FXIII
2/2 that received 5 days of FXIII replacement therapy
had normal survival rates, although cardiac MRI demonstrated
worse LV remodeling in these reconstituted FXIII
2/2. Likewise,
skin healing was impaired in the same mouse model [3]. In
conclusion, the reported clinical experiences and the parallel
experimental data support the hypothesis that FXIII deficiency
may impair healing in patients with MI while replacement therapy
may alleviate complications. A prospective study is warranted to
determine the clinical significance of these findings.
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A: Short axis high resolution, high field cardiac MRI of a FXIII
2/2 mouse 2 days after coronary ligation. Arrows: intrathoracic hematoma adjacent to
experimental anterolateral infarction.
B: Autopsy confirms a blood clot (asterisk) originating from myocardial rupture at the border zone (arrow) of the myocardial infarct.
C: Histology of 1A shows rupture channel (arrows), filled with blood.
D: In patients with ruptured MI, FXIII levels were significantly reduced (*p,0.01).
E: Color Doppler echo of patient with new ventricular septum defect 7 days after myocardial infarction (arrow).
F: MRI after VSD repair with patch (arrows).
G–I: Explantation site of saphenous veins for CABG surgery displays delayed healing.
J: 73 days after initial surgery, 3 revisions and 2 weeks after i.v. FXIII augmentation, the wound is closed.
doi:10.1371/journal.pone.0000048.g001
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